Health Care & Life Sciences » Pharmaceuticals | Heron Therapeutics Inc.

Heron Therapeutics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
72,287.00
72,675.00
131,166.00
51,138.00
172,379.00
332,371
Total Accounts Receivable
-
-
-
1,960.00
41,874.00
64,652
Inventories
-
-
-
5,340.00
10,108.00
39,032
Other Current Assets
638.00
1,057.00
3,585.00
3,705.00
3,702.00
11,193
Total Current Assets
72,925.00
73,732.00
134,751.00
62,143.00
228,063.00
447,248
Net Property, Plant & Equipment
2,882.00
2,820.00
3,049.00
5,076.00
5,981.00
14,677
Other Assets
130.00
130.00
45.00
263.00
263.00
254
Total Assets
75,937.00
76,682.00
137,845.00
67,482.00
234,307.00
462,179
ST Debt & Current Portion LT Debt
1,025.00
1,598.00
2,222.00
2,911.00
28,684.00
Accounts Payable
1,264.00
-
-
6,814.00
18,769.00
Other Current Liabilities
4,703.00
12,022.00
17,513.00
29,008.00
55,718.00
Total Current Liabilities
6,992.00
13,620.00
19,735.00
38,733.00
103,171.00
Long-Term Debt
-
-
-
50,000.00
-
Total Liabilities
6,992.00
13,620.00
19,735.00
88,733.00
103,171.00
Common Equity (Total)
68,945.00
63,062.00
118,110.00
21,251.00
131,136.00
Total Shareholders' Equity
68,945.00
63,062.00
118,110.00
21,251.00
131,136.00
Total Equity
68,945.00
63,062.00
118,110.00
21,251.00
131,136.00
Liabilities & Shareholders' Equity
75,937.00
76,682.00
137,845.00
67,482.00
234,307.00

About Heron Therapeutics

View Profile
Address
4242 Campus Point Court
San Diego California 92121
United States
Employees -
Website http://www.herontx.com
Updated 07/08/2019
Heron Therapeutics, Inc. is a biotechnology company, which develops pharmaceutical products for patients suffering from cancer. The company develops products by using its proprietary Biochronomer polymer based drug delivery technology. Its products include SUSTOL, Pipeline, Cinvanti and HTX-011.